Cannara Biotech Financials
| LOVFF Stock | USD 0.52 0.09 20.93% |
With this module, you can analyze Cannara financials for your investing period. You should be able to track the changes in Cannara Biotech individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Cannara |
Understanding current and past Cannara Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cannara Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Cannara Biotech's assets may result in an increase in income on the income statement.
The data published in Cannara Biotech's official financial statements typically reflect Cannara Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cannara Biotech's quantitative information. For example, before you start analyzing numbers published by Cannara accountants, it's essential to understand Cannara Biotech's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Cannara Biotech Stock Summary
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. Cannara Biotech is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 333 Decarie Blvd, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | cannara.ca |
| Phone | 514 543 4200 |
| Currency | USD - US Dollar |
Cannara Biotech Key Financial Ratios
There are many critical financial ratios that Cannara Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cannara Biotech reports annually and quarterly.| Return On Equity | 0.0434 | |||
| Return On Asset | 0.0327 | |||
| Beta | 1.52 | |||
| Z Score | 0.6 |
Cannara Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cannara Biotech's current stock value. Our valuation model uses many indicators to compare Cannara Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannara Biotech competition to find correlations between indicators driving Cannara Biotech's intrinsic value. More Info.Cannara Biotech is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.75 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cannara Biotech is roughly 1.33 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cannara Biotech's earnings, one of the primary drivers of an investment's value.Cannara Biotech Systematic Risk
Cannara Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cannara Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cannara Biotech correlated with the market. If Beta is less than 0 Cannara Biotech generally moves in the opposite direction as compared to the market. If Cannara Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cannara Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cannara Biotech is generally in the same direction as the market. If Beta > 1 Cannara Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Cannara Biotech November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cannara Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cannara Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cannara Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Cannara OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cannara Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 36.67 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 8.51 |
Complementary Tools for Cannara OTC Stock analysis
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |